186 related articles for article (PubMed ID: 27439965)
1. Complex Transfusion Issues in Pediatric Hematopoietic Stem Cell Transplantation.
Webb J; Abraham A
Transfus Med Rev; 2016 Oct; 30(4):202-8. PubMed ID: 27439965
[TBL] [Abstract][Full Text] [Related]
2. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
3. Clinical guide to ABO-incompatible allogeneic stem cell transplantation.
Booth GS; Gehrie EA; Bolan CD; Savani BN
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1152-8. PubMed ID: 23571461
[TBL] [Abstract][Full Text] [Related]
4. Transfusion policy in allogeneic hematopoietic stem cell transplantation.
Topcuoglu P
Transfus Apher Sci; 2018 Apr; 57(2):174-177. PubMed ID: 29724631
[TBL] [Abstract][Full Text] [Related]
5. Transfusion support issues in hematopoietic stem cell transplantation.
Cohn CS
Cancer Control; 2015 Jan; 22(1):52-9. PubMed ID: 25504279
[TBL] [Abstract][Full Text] [Related]
6. Management of hemolytic anemia following allogeneic stem cell transplantation.
Holbro A; Passweg JR
Hematology Am Soc Hematol Educ Program; 2015; 2015():378-84. PubMed ID: 26637746
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
Cunard R; Marquez II; Ball ED; Nelson CL; Corringham S; Clopton P; Sanchez AP; Lane T; Ward DM
Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
[TBL] [Abstract][Full Text] [Related]
8. Results of two protocols for platelet transfusion in patients undergoing abo incompatible hematopoietic stem cell transplantation.
Solves P; Diaz Á; Carretero C; Gómez I; Carpio N; Sanz G
Transfus Apher Sci; 2019 Apr; 58(2):185-186. PubMed ID: 30910618
[No Abstract] [Full Text] [Related]
9. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
11. Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.
Worel N; Böhm A; Rabitsch W; Leitner G; Mitterbauer M; Kalhs P; Mayr WR; Schwartz D; Greinix HT
Transfusion; 2012 Jun; 52(6):1348-53. PubMed ID: 22128859
[TBL] [Abstract][Full Text] [Related]
12. Immunohematologic issues in ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Akkök ÇA; Seghatchian J
Transfus Apher Sci; 2018 Dec; 57(6):812-815. PubMed ID: 30404742
[TBL] [Abstract][Full Text] [Related]
13. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report.
Jaben EA; Jacob EK; Tauscher C; D'Souza A; Hogan WJ; Stubbs JR
Transfusion; 2013 Jan; 53(1):202-5. PubMed ID: 22574682
[TBL] [Abstract][Full Text] [Related]
14. Hemolysis from ABO Incompatibility.
Simmons DP; Savage WJ
Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
[TBL] [Abstract][Full Text] [Related]
15. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
Atay D; Erbey F; Akcay A; Ozturk G
Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
17. [Study on serological blood group conversion rule and clinical blood transfusion in allogeneic hematopoietic stem cell transplantation].
Yu ZQ; Gao ZF; Li HY
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):637-41. PubMed ID: 23134859
[TBL] [Abstract][Full Text] [Related]
18. Transfusions after nonmyeloablative or reduced-intensity conditioning regimens.
Baron F; Vanstraelen G; Beguin Y
Leukemia; 2006 Dec; 20(12):2081-6. PubMed ID: 17039229
[No Abstract] [Full Text] [Related]
19. Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience.
Elemary M; Seghatchian J; Stakiw J; Bosch M; Sabry W; Goubran H
Transfus Apher Sci; 2017 Jun; 56(3):317-321. PubMed ID: 28642120
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
